Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126564) titled 'To evaluate the efficacy and safety of nintedanib in combination with glucocorticoids compared with glucocorticoids alone in the treatment of pneumonitis (RP): a randomized controlled multicenter clinical trial' on June 11.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The Affiliated Cancer Hospital of Shandong First Medical University
Condition:
Lung cancer
Intervention:
Experimental group:Nintedanib in combination with glucocorticoids
Recruitment Status: Recruiting
Phase: 4
Date of First Enrollment: 2025-12-16
Target Sample Size: Experimental group:72;Control group:72; ...